| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.55B | +3.8% |
| Cost of Revenue | $1.48B | +4.2% |
| Gross Profit | $1.07B | +3.4% |
| R&D Expense | $67.6M | +7.3% |
| SG&A Expense | $660.7M | +5.1% |
| Operating Income | $342.2M | -0.5% |
| Pre-tax Income | $265.6M | -7.7% |
| Income Tax | $74.6M | +66.5% |
| Net Income | $190.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $626.5M | +74.3% |
| Accounts Receivable | $517.7M | +17.8% |
| Inventory | $294.7M | +19.7% |
| Current Assets | $1.58B | +24.6% |
| Total Assets | $5.10B | +4.7% |
| Current Liabilities | $429.9M | +13.2% |
| Long-term Debt | $1.64B | -11.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $62.2M | -9.1% |
| Investing Cash Flow | $286.1M | +487.7% |
| Financing Cash Flow | -$320.4M | -55.1% |
| -21.9% |
| EPS (Basic) | $0.79 | -21.8% |
| EPS (Diluted) | $0.79 | -21.8% |
| Total Liabilities |
| $2.41B |
| -2.6% |
| Stockholders' Equity | $2.67B | +12.2% |